BIOHK2022: Hong Kong needs a more integrated and harmonised ecosystem to become a biotech fundraising hub, panellists say

December 15, 2022 Chin@Strategy

From left, Bin Li of Lake Bleu Capital, Vijay Karwal of AffaMed Therapeutics, Donald Lung, CFO of Antengene and Yinxiang Wang, chairman and CEO of Jacobio Pharma, take part in a panel discussion on ‘Capital Market for Healthcare Post Pandemic’ at BIOHK2022 on Thursday. Photo: Handout

South China Morning Post

Related posts

• 

  June 17, 2025 Media Library 0

  After tight-lipped talks in London, the US-China silence speaks volumes

  With global economic ramifications on the line, those with a vested interest in supply chains and...

• 

  June 17, 2025 Media Library 0

  China condemns US after plan to replace Huawei towers in Panama is unveiled

  Following a US announcement of a project in Panama to replace communications towers installed by Chinese...

• 

  June 17, 2025 Media Library 0

  Greta Thunberg, once unpopular on Chinese social media, rises in esteem on Gaza

  Greta Thunberg, the Swedish environmental activist once widely criticised on Chinese social media, appears to be...